Literature DB >> 14662887

Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding.

Xinle Cui1, Farshid N Rouhani, Feras Hawari, Stewart J Levine.   

Abstract

Proteolytic cleavage of the extracellular domain of the type II IL-1 decoy receptor (IL-1RII) generates soluble IL-1-binding proteins that prevent excessive bioactivity by binding free IL-1. In this study we report that an aminopeptidase, aminopeptidase regulator of TNFR1 shedding (ARTS-1), is required for IL-1RII shedding. Coimmunoprecipitation experiments demonstrate an association between endogenous membrane-associated ARTS-1 and a 47-kDa IL-1RII, consistent with ectodomain cleavage of the membrane-bound receptor. A direct correlation exists between ARTS-1 protein expression and IL-1RII shedding, as cell lines overexpressing ARTS-1 have increased IL-1RII shedding and decreased membrane-associated IL-1RII. Basal IL-1RII shedding is absent from ARTS-1 knockout cell lines, demonstrating that ARTS-1 is required for constitutive IL-1RII shedding. Similarly, PMA-mediated IL-1RII shedding is almost entirely ARTS-1-dependent. ARTS-1 expression also enhances ionomycin-induced IL-1RII shedding. ARTS-1 did not alter levels of membrane-associated IL-1RI or IL-1R antagonist release from ARTS-1 cell lines, which suggests that the ability of ARTS-1 to promote shedding of IL-1R family members may be specific for IL-1RII. Further, increased IL-1RII shedding by ARTS-1-overexpressing cells attenuates the biological activity of IL-1beta. We conclude that the ability of ARTS-1 to enhance IL-1RII shedding represents a new mechanism by which IL-1-induced cellular events can be modulated. As ARTS-1 also promotes the shedding of the structurally unrelated 55-kDa, type I TNF receptor and the IL-6R, we propose that ARTS-1 may play an important role in regulating innate immune and inflammatory responses by increasing cytokine receptor shedding.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14662887     DOI: 10.4049/jimmunol.171.12.6814

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  56 in total

Review 1.  Endoplasmic reticulum aminopeptidases: Biology and pathogenic potential.

Authors:  Nigil Haroon; Robert D Inman
Journal:  Nat Rev Rheumatol       Date:  2010-06-08       Impact factor: 20.543

2.  Susceptibility to ankylosing spondylitis: evidence for the role of ERAP1, TGFb1 and TLR9 gene polymorphisms.

Authors:  Wenliang Wu; Yan Ding; Yunzhen Chen; Zhao Hua; Haichun Liu; Hongliang Wang; Guangjun Jiao
Journal:  Rheumatol Int       Date:  2011-07-16       Impact factor: 2.631

Review 3.  Molecular and cellular mechanisms of ectodomain shedding.

Authors:  Kazutaka Hayashida; Allison H Bartlett; Ye Chen; Pyong Woo Park
Journal:  Anat Rec (Hoboken)       Date:  2010-06       Impact factor: 2.064

4.  Inflammasome activation and IL-1β target IL-1α for secretion as opposed to surface expression.

Authors:  Antonia Fettelschoss; Magdalena Kistowska; Salomé LeibundGut-Landmann; Hans-Dietmar Beer; Pål Johansen; Gabriela Senti; Emmanuel Contassot; Martin F Bachmann; Lars E French; Annette Oxenius; Thomas M Kündig
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

5.  Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1).

Authors:  Despoina Koumantou; Eilon Barnea; Adrian Martin-Esteban; Zachary Maben; Athanasios Papakyriakou; Anastasia Mpakali; Paraskevi Kokkala; Harris Pratsinis; Dimitris Georgiadis; Lawrence J Stern; Arie Admon; Efstratios Stratikos
Journal:  Cancer Immunol Immunother       Date:  2019-06-20       Impact factor: 6.968

6.  Entheses and bones in spondyloarthritis: 2008 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN).

Authors:  Robert A Colbert; Atul A Deodhar; David Fox; Ellen M Gravallese; Muhammad Asim Khan; Dennis McGonagle; John D Reveille; Georg Schett; Michael Weisman; Daniel O Clegg
Journal:  J Rheumatol       Date:  2009-07       Impact factor: 4.666

7.  The association between seven ERAP1 polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis involving 8,530 cases and 12,449 controls.

Authors:  Rui Chen; Lei Yao; Tong Meng; Weidong Xu
Journal:  Rheumatol Int       Date:  2011-01-13       Impact factor: 2.631

8.  Association between ERAP1 gene polymorphisms and ankylosing spondylitis susceptibility in Han population.

Authors:  Jian Wang; Hang Li; Jianwei Wang; Xiang Gao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

9.  The effects of interleukin-1beta in tumor necrosis factor-alpha-induced acute pulmonary inflammation in mice.

Authors:  Sara Saperstein; Heidie Huyck; Elizabeth Kimball; Carl Johnston; Jacob Finkelstein; Gloria Pryhuber
Journal:  Mediators Inflamm       Date:  2009-11-04       Impact factor: 4.711

10.  Investigating the genetic association between ERAP1 and ankylosing spondylitis.

Authors:  David Harvey; Jennifer J Pointon; David M Evans; Tugce Karaderi; Claire Farrar; Louise H Appleton; Roger D Sturrock; Millicent A Stone; Udo Oppermann; Matthew A Brown; B Paul Wordsworth
Journal:  Hum Mol Genet       Date:  2009-08-18       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.